Literature DB >> 24077407

Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection.

Jeremiah L Deneve1, Jane L Messina, Marilyn M Bui, Suroosh S Marzban, G Douglas Letson, David Cheong, Ricardo J Gonzalez, Vernon K Sondak, Jonathan S Zager.   

Abstract

BACKGROUND: Cutaneous leiomyosarcoma is primarily a low-grade malignancy that affects elderly male Caucasians. It is a rare dermal-based tumor for which treatment algorithms have been poorly defined.
METHODS: We retrospectively reviewed the use of a median 1-cm margin for resection to treat patients with cutaneous leiomyosarcoma referred for treatment between 2005 and 2010.
RESULTS: Thirty-three patients with cutaneous leiomyosarcoma were treated. Of these, 76% were male, 97% were Caucasian (median age: 63.5 years), and 67% of tumors were located on the extremities. Preoperative staging was negative for distant metastasis in all patients. A majority of the tumors (88%) were low grade (median size: 1.3 cm). All of the tumors were positive for smooth-muscle actin. A total of 94% of patients underwent primary surgical resection with a median margin of 1 cm. Final resection margin was negative in 97% of patients. Adjuvant radiotherapy was used in 15%. No metastatic spread or recurrences were present, and 100% of patients were alive at last follow-up (median: 15.5 months).
CONCLUSIONS: Good oncological control and excellent outcomes are possible with a 1-cm resection margin in most cases of cutaneous leiomyosarcoma.

Entities:  

Mesh:

Year:  2013        PMID: 24077407      PMCID: PMC4504421          DOI: 10.1177/107327481302000408

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  27 in total

Review 1.  The epidemiology of soft tissue sarcoma.

Authors:  S H Zahm; J F Fraumeni
Journal:  Semin Oncol       Date:  1997-10       Impact factor: 4.929

Review 2.  Cutaneous leiomyosarcoma: a tumor of the head and neck.

Authors:  Nicole M Annest; Sarah J Grekin; Mary Seabury Stone; Michael J Messingham
Journal:  Dermatol Surg       Date:  2007-05       Impact factor: 3.398

3.  Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases.

Authors:  Gelareh Farshid; Malcolm Pradhan; John Goldblum; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

4.  Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.

Authors:  T A Alvegard; N O Berg; B Baldetorp; M Fernö; D Killander; J Ranstam; A Rydholm; M Akerman
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

5.  Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".

Authors:  Stefan Kraft; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

6.  Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations.

Authors:  T Konomoto; T Fukuda; K Hayashi; J Kumazawa; M Tsuneyoshi
Journal:  Hum Pathol       Date:  1998-01       Impact factor: 3.466

7.  Leiomyosarcoma of the skin and subcutaneous tissue.

Authors:  J P Fields; E B Helwig
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

Review 8.  Leiomyosarcoma of the skin. Treatment of 34 cases.

Authors:  S C Bernstein; R K Roenigk
Journal:  Dermatol Surg       Date:  1996-07       Impact factor: 3.398

9.  Prognostic significance of Ki-67 reactivity in soft tissue sarcomas.

Authors:  T Ueda; K Aozasa; M Tsujimoto; M Ohsawa; A Uchida; Y Aoki; K Ono; K Matsumoto
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

10.  The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma.

Authors:  Justin Pijpe; Gerben H Torn Broers; Boudewijn E Ch Plaat; M Hundeiker; F Otto; Mirjam F Mastik; Harald J Hoekstra; Winette T A van der Graaf; Eva van Den Berg; Willemina M Molenaar
Journal:  Sarcoma       Date:  2002
View more
  7 in total

1.  Leiomyosarcoma of the Face.

Authors:  Young-Il Ko; Jin-Soo Lim; Ki-Taik Han; Min-Cheol Kim
Journal:  Arch Craniofac Surg       Date:  2014-04-10

Review 2.  Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment.

Authors:  Martina Zacher; Markus V Heppt; Titus J Brinker; Kinan M Hayani; Michael J Flaig; Carola Berking
Journal:  Med Oncol       Date:  2018-08-23       Impact factor: 3.064

3.  Delayed diagnosis of dermal leiomyosarcoma mimicking keloid scar.

Authors:  Aseel Sleiwah; Aoibhinn Clinton; Kevin Herbert
Journal:  BMJ Case Rep       Date:  2018-01-26

Review 4.  Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy.

Authors:  Fien Hoefkens; Charlotte Dehandschutter; Johan Somville; Paul Meijnders; Dirk Van Gestel
Journal:  Radiat Oncol       Date:  2016-10-12       Impact factor: 3.481

5.  Periorbital leiomyosarcoma treated by means of conventional surgery and frontal myocutaneous flap.

Authors:  Priscilla Kelly Soares Torres Brito; Victor Miguel Coutinho Fernandes; Humberto David Menezes de Siqueira Brito; Mohamed Arbaqui Azzouz; Anélia Carneiro Souza; Klécius Leite Fernandes
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

Review 6.  Cutaneous leiomyosarcoma on the trunk: An unusual presentation with an aggressive course - Case report and review of literature.

Authors:  Lina Hmida; Feryel Letaief; Raoudha Doghri; Khedija Meddeb; Khalil Mahjoubi; Amina Mokrani; Yosra Yahiaoui; Azza Gabsi; Nesrine Cheraiet; Henda Rais; Mouna Ayadi; Amel Mezlini
Journal:  Pan Afr Med J       Date:  2018-11-19

Review 7.  Cutaneous soft tissue sarcomas: survival-related factors.

Authors:  Areti Gkantaifi; Alexandros Diamantis; Davide Mauri; Ioanna Nixon; Anastassios Kyriazoglou; Ioannis Baloyiannis; Nikolaos Tsoukalas; Nikolaos Charalampakis; Dimitrios Schizas; Francesco Cuccia; Filippo Alongi; Ramon Andrade de Mello; George Iliadis; Konstantinos Kamposioras; Michalis Mazonakis; Maria Tolia
Journal:  Arch Dermatol Res       Date:  2021-07-17       Impact factor: 3.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.